Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RB-ADSC in Mild to Moderate Alzheimer's Disease
NCT07205601Phase 2Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Feb 2029
- Modality
- Mesenchymal Stem Cells, Patient-derived iPSCs, Allogeneic iPSCs
01
Overview
A Phase 2 trial of astrostem in Alzheimer's disease (AD). Planned start Oct 2026; status: not yet recruiting.
02
Drugs
astrostem
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07205601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07205601.